Brigatinib in Crizotinib-Refractory ALK plus NSCLC: Central Assessment and Updates from ALTA, a Pivotal Randomized Phase 2 Trial

被引：11

作者：

Camidge, D. Ross ^{[1
]}

Tiseo, Marcello ^{[2
]}

Ahn, Myung-Ju ^{[3
]}

Reckamp, Karen ^{[4
]}

Hansen, Karin ^{[5
]}

Kim, Sang-We ^{[6
]}

Huber, Rudolf ^{[7
]}

West, Howard ^{[8
]}

Groen, Harry ^{[9
]}

Hochmair, Maximilian ^{[10
]}

Leighl, Natasha ^{[11
]}

Gettinger, Scott ^{[12
]}

Langer, Corey ^{[13
]}

Paz-Ares, Luis ^{[14
]}

Smit, Egbert ^{[15
]}

Kim, Edward ^{[16
]}

Reichmann, William ^{[17
]}

Clackson, Tim ^{[17
]}

Kerstein, David ^{[17
]}

Haluska, Frank ^{[17
]}

Kim, Dong-Wan ^{[18
]}

机构：

[1] Univ Colorado, Ctr Canc, Aurora, CO USA

[2] Univ Hosp Parma, Med Oncol, Parma, Italy

[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Meidicine, Seoul, South Korea

[4] City Hope Comprehens Canc Ctr, Duarte, CA USA

[5] Odense Univ Hosp, Odense, Denmark

[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[7] Univ Hosp Munich, Munich, Germany

[8] Swedish Canc Inst, Med Oncol, Seattle, WA USA

[9] Univ Med Ctr Groningen, Groningen, Netherlands

[10] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria

[11] Princess Margaret Canc Ctr, Med Oncol, Toronto, ON, Canada

[12] Yale Canc Ctr, New Haven, CT USA

[13] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[14] Hosp Univ Doce Octubre, Madrid, Spain

[15] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[16] Carolinas Healthcare Syst, Levine Canc Inst, Solid Tumor Oncol, Charlotte, NC USA

[17] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

[18] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

ALK; brigatinib; NSCLC; TKI;

D O I：

10.1016/j.jtho.2016.11.1643

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.02a-013

引用

页码：S1167 / S1169

页数：3

共 25 条

[21] A Randomized, Phase 3 Study of Iruplinalkib (WX-0593) vs Crizotinib in Locally Advanced or Metastatic ALK plus Non-small Cell Lung Cancer (NSCLC)
Shi, Y.
Chen, J.
Yang, R.
Wu, H.
Wang, Z.
Yang, W.
Cui, J.
Zhang, Y.
Liu, C.
Cheng, Y.
Liu, Y.
Shan, J.
Wang, D.
Yang, L.
Hu, C.
Zhao, J.
Cao, R.
Tan, B.
Xu, K.
Si, M.
Li, H.
Mao, R.
Li, L.
Kang, X.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S49 - S50
[22] Repotrectinib in Patients with ROS1 Fusion-positive (ROS1+) NSCLC: Update from the Pivotal Phase 1/2 TRIDENT-1 Trial
Cho, B. C.
Camidge, D. R.
Lin, J. J.
Kim, S. -W.
Solomon, B.
Dziadziuszko, R.
Besse, B.
Goto, K.
de Langen, A. J.
Wolf, J.
Lee, K. H.
Popat, S.
Springfeld, C.
Nagasaka, M.
Felip, E.
Yang, N.
Lu, S.
Kao, S.
Velcheti, V.
Cheema, P.
Stopatschinskaja, S.
Mehta, M.
Trone, D.
Ades, F.
Calvet, C. Y.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S50 - S51
[23] Long Term Efficacy of SNK01 Plus Pembrolizumab for NSCLC: Expanded Observation from a Phase I/II A Randomized Controlled Trial
Park, H.
Jung, J. S.
Kim, Y. M.
Kang, Y.
Ji, W.
Lee, J. C.
Choi, C. -M.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S463 - S464
[24] Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial
Solomon, Benjamin J.
Dagogo-Jack, Ibiayi
Lee, Se-Hoon
Boyer, Michael J.
Ramalingam, Suresh S.
Carcereny, Enric
Felip, Enriqueta
Han, Ji-Youn
Hida, Toyoaki
Hughes, Brett G. M.
Kim, Sang -We
Nishio, Makoto
Seto, Takashi
Okamoto, Tatsuro
Zhang, Xiaoxi
Martini, Jean -Francois
Wang, Erjian
De Beukelaer, Steven
Bauer, Todd M.
JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (07):
[25] SUBSET ANALYSES OF EAST ASIAN PATIENTS ENROLLED IN THE MISSION PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SORAFENIB MONOTHERAPY IN PATIENTS WITH ADVANCED RELAPSED/REFRACTORY NSCLC OF PREDOMINANTLY NON-SQUAMOUS HISTOLOGY WHO FAILED 2-3 CHEMOTHERAPY REGIMENS
Mok, Tony S. K.
Wu, Yi-long
Zhou, Caicun
Sun, Yan
Zhang, Li
Liao, Meilin
Qin, Shukui
Seto, Takashi
Atagi, Shinji
Okamoto, Isamu
Park, Keunchil
Kang, Jin Hyung
Yang, J. C.
Chang, Gee-chen
Soo, Ross
Pena, Carol
Maeda, Patricia
Ong, Ten Jing
Schmelter, Thomas
Paz-Ares, Luis
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458

← 1 2 3 →